Cost-effectiveness Analysis of Manidipine versus Amlodipine as an Add-on to Renin-angiotensin System Blockers in Hypertensive Patients with Diabetes and Proteinuria

Wiwat Thavornwattanayong

[(W)P-121] Cost-effectiveness Analysis of Manidipine versus Amlodipine as an Add-on to Renin-angiotensin System Blockers in Hypertensive Patients with Diabetes and Proteinuria

^○Wiwat Thavornwattanayong¹, Kamolpat Chaiyakittisopon², Jadesada Lertsirimunkong³ (1.Silpakorn University, 2.Silpakorn University, 3.Rangsit University)

Abstract password authentication.
The password has been announced for Pre-registered participants by email.
You can also find the password in the Pocket program distributed at the venue.

Presentation information

[PP-8] Health economics

[(W)P-121] Cost-effectiveness Analysis of Manidipine versus Amlodipine as an Add-on to Renin-angiotensin System Blockers in Hypertensive Patients with Diabetes and Proteinuria

Password